Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion

Japanese Journal of Ophthalmology

Volumn 55, Issue 3, 2011, Pages 256-263

  Suzuki, Yukihiko ^a   Nakazawa, Mitsuru ^a   Suzuki, Kaori ^a   Yamazaki, Hitoshi ^a   Miyagawa, Yasuhiro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Central retinal vein occlusion; Chemokines; Cytokines; Diabetic retinopathy; Vascular endothelial growth factor; Vitreous fluid

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HUMAN; MALE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; VITREOUS BODY;

AGED; CHEMOKINES; CYTOKINES; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; FEMALE; HUMANS; MALE; MIDDLE AGED; RETINAL PERFORATIONS; RETINAL VEIN OCCLUSION; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

EID: 79960072567     PISSN: 00215155     EISSN: 16132246     Source Type: Journal    
DOI: 10.1007/s10384-011-0004-8     Document Type: Article

References (35)

1. TC Hohman C Nishimura WG Robison Jr 1989 Aldose reductase and polyol in cultured pericytes of human retinal capillaries Exp Eye Res 48 55 60 2493386 10.1016/0014-4835(89)90018-3 1:CAS:528:DyaL1MXpt1Cqtw%3D%3D (Pubitemid 19046246)
2. Y Takamura T Tomomatsu E Kubo S Tsuzuki Y Akagi 2008 Role of the polyol pathway in high glucose-induced apoptosis of retinal pericytes and proliferation of endothelial cells Invest Ophthalmol Vis Sci 49 3216 3223 18362110 10.1167/iovs.07-1643
3. D Cogan D Toussaint T Kuwabara 1961 Retinal vascular pattern. IV. Diabetic retinopathy Arch Ophthalmol 66 366 378 13694291 1:STN:280: DyaF3c%2FhtlKgug%3D%3D
4. H-P Hammes J Lin O Renner M Shani A Lundqvist C Betsholtz, et al. 2002 Pericytes and the pathogenesis of diabetic retinopathy Diabetes 51 3107 3112 12351455 10.2337/diabetes.51.10.3107 1:CAS:528:DC%2BD38XnslGhsbw%3D
5. A Garner 1993 Histopathology of diabetic retinopathy in man Eye 7 250 253 7607344 (Pubitemid 23153118)
6. GH Bresnick 1983 Diabetic maculopathy: a critical review highlighting diffuse macular edema Ophthalmology 90 1301 1317 6664669 1:STN:280: DyaL2c7hvVaquw%3D%3D (Pubitemid 14200813)
7. A Pfeiffer J Spranger R Meyer-Schwickerath H Schatz 1997 Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown Diabetes 46 S26 S30 9285495 1:CAS:528:DyaK2sXlvFKgtbg%3D
8. RG Tilton 2002 Diabetic vascular dysfunction: links to glucose-induced reductive stress and VEGF Microsc Res Tech 57 390 407 12112445 10.1002/jemt.10092 1:CAS:528:DC%2BD38Xlt1Crt7s%3D (Pubitemid 34579219)
9. LP Aiello RL Avery PG Arrigg BA Keyt HD Jampel ST Shah, et al. 1994 Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders N Engl J Med 331 1480 1487 7526212 10.1056/NEJM199412013312203 1:STN:280:DyaK2M%2FlvFamsA%3D%3D (Pubitemid 24356306)
10. N Ogata M Nishikawa T Nishimura Y Mitsuma M Matsumura 2002 Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy Am J Ophthalmol 134 348 353 12208245 10.1016/S0002-9394(02)01568-4 1:CAS:528:DC%2BD38Xms1Kgtbg%3D
11. H Funatsu H Yamashita T Ikeda T Mimura S Eguchi S Hori 2003 Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema Ophthalmology 110 1690 1696 13129863 10.1016/S0161- 6420(03)00568-2 (Pubitemid 37025424)
12. H Funatsu H Yamashita K Sakata H Noma T Mimura M Suzuki, et al. 2005 Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema Ophthalmology 112 806 816 15878060 10.1016/j.ophtha.2004.11.045 (Pubitemid 40631499)
13. H Funatsu H Yamashita S Nakamura T Mimura S Eguchi H Noma, et al. 2006 Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema Ophthalmology 113 294 301 16406543 10.1016/j.ophtha.2005.10.030 (Pubitemid 43170779)
14. E Ishizaki S Takai M Ueki T Maeno M Maruichi T Sugiyama, et al. 2006 Correlation between angiotensin-converting enzyme, vascular endothelial growth factor, and matrix metalloproteinase-9 in the vitreous of eyes with diabetic retinopathy Am J Ophthalmol 141 129 134 16386986 10.1016/j.ajo.2005.08.066 1:CAS:528:DC%2BD2MXhtlGlsrnP (Pubitemid 43016182)
15. M Kawashima J Shoji Y Yoshimura Y Sato 2005 Role of chemokines in the vitreous of proliferative diabetic retinopathy Nippom Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc) 109 596 602 1:CAS:528:DC%2BD2MXhtF2qsL%2FE
16. K Chen C Wu S Roy SM Lee JH Liu 1999 Increased interleukin-6 in aqueous humor of neovascular glaucoma Int Ophthalmol Vis Sci 40 2627 2632 1:STN:280:DyaK1Mvjslemug%3D%3D (Pubitemid 29455493)
17. Boyd SR, Zachary I, Chakravarthy U, Allen GJ, Wisdom GB, Cree IA, et al. Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion. Arch Ophthalmol. 2002;120:1644-50. (Pubitemid 36401798)
18. M Kawashima J Shoji M Nakajima Y Kamura Y Sato 2006 Investigation of angiogenic factors in the vitreous and serum of proliferative diabetic retinopathy patients, using a simultaneous detection method with an antibody array Nihon Univ J Med 48 125 135 1:CAS:528:DC%2BD2sXmvVegt7s%3D
19. Central Vein Occlusion Study Group. Baseline and early natural history report: the Central Vein Occlusion Study. Arch Ophthalmol. 1993;111:1087-95.
20. H Noma H Funatsu M Yamasaki H Tsukamoto T Mimura T Sone, et al. 2005 Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6 Am J Ophthalmol 140 256 261 16086947 10.1016/j.ajo.2005.03.003 1:CAS:528:DC%2BD2MXns1WmsL8%3D (Pubitemid 41125805)
21. R Maier M Weger E-M Haller-Schober Y El-Shabrawi A Wedrich A Theisel, et al. 2008 Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients Mol Vis 14 637 643 18385799 1:CAS:528:DC%2BD1cXlt1OlsL4%3D (Pubitemid 351486723)
22. Y Wakabayashi Y Usui Y Okunuki T Kezuka M Takeuchi H Goto, et al. 2010 Correlation of vascular endothelial growth factor with chemokines in the vitreous in diabetic retinopathy Retina 30 339 344 20142713 10.1097/IAE. 0b013e3181bd2f44
23. T Yoshimura K Sonoda M Sugahara Y Mochizuki H Enaida Y Oshima, et al. 2009 Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases PLoS ONE 4 e8158 19997642 10.1371/journal.pone.0008158
24. T Sato S Kusaka H Shimojo T Fujikado 2009 Simultaneous analysis of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity Ophthalmology 116 2165 2169 19700197 10.1016/j.ophtha.2009.04.026
25. E Rungger-Brändle AA Dosso PM Leuenberger 2000 Glial reactivity, an early feature of diabetic retinopathy Invest Ophthalmol Vis Sci 41 1971 1980 10845624 (Pubitemid 30354375)
26. C Haritoglou D Kook A Neubauer A Wolf S Priglinger R Strauss, et al. 2006 Intravitreal bevacizumab (avastin) therapy for persistent diffuse diabetic macular edema Retina 26 999 1005 17151486 10.1097/01.iae.0000247165.38655.bf (Pubitemid 44973218)
27. JF Arevalo J Fromow-Guerra H Quiroz-Mercado JG Sanchez L Wu M Maia, et al. 2007 Primary intravitreal bevacizumab (avastin) for diabetic macular edema Ophthalmology 114 743 750 17398322 10.1016/j.ophtha.2006.12.028 (Pubitemid 46483714)
28. A Martidis JS Duker PB Greenberg AH Rogers CA Puliafito E Reichel, et al. 2002 Intravitreal triamcinolone for refractory diabetic macular edema Ophthalmology 109 920 927 11986098 10.1016/S0161-6420(02)00975-2 (Pubitemid 34465226)
29. JB Jonas I Kreissig A Söfker RF Degenring 2003 Intravitreal injection of triamcinolone for diffuse diabetic macular edema Arch Ophthalmol 121 57 61 12523885 10.1001/archopht.121.5.729 1:CAS:528:DC%2BD3sXps1KqsQ%3D%3D (Pubitemid 36554480)
30. LK Verma MB Vivek A Kumar HK Tewari P Venkatesh 2004 A prospective controlled trial to evaluate the adjunctive role of posterior subtenon triamcinolone in the treatment of diffuse macular edema J Ocul Pharmacol Ther 20 277 284 15321022 10.1089/1080768041725308 1:CAS:528:DC%2BD2cXmvVart74%3D (Pubitemid 39108892)
31. N Ohguro AA Okada Y Tano 2004 Trans-Tenon's retrobulbar triamcinolone infusion for diffuse diabetic macular edema Graefes Arch Clin Exp Ophthalmol 242 444 445 14747952 10.1007/s00417-003-0853-z (Pubitemid 38801536)
32. PB Greenberg A Martidis AH Rogers JS Duker E Reichel 2002 Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion Br J Ophthalmol 86 247 248 11815359 10.1136/bjo.86.2.247 (Pubitemid 34127557)
33. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2002;240:782-3. (Pubitemid 36097108)
34. PJ Rosenfeld AE Fung CA Puliafito 2005 Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion Ophthalmic Surg Lasers Imaging 36 336 339 16156153 (Pubitemid 41073113)
35. RA Costa R Jorge D Calucci LA Melo JA Cardillo IU Scott 2007 Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusion: IBeVO study Retina 27 141 149 17290194 10.1097/IAE.0b013e31802eff83